Cargando…

Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI

The aim of the present study was to evaluate the use of preoperative high-dose atorvastatin to prevent the no-reflow phenomenon after percutaneous coronary intervention (PCI). A total of 138 patients with ST-segment elevation myocardial infarction, admitted from March 2014 to January 2015, were enro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenbo, Zou, Zhipeng, Jiang, Haipeng, Li, Qiang, Guo, Fangming, Wang, Zhen, Zhu, Hongguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244837/ https://www.ncbi.nlm.nih.gov/pubmed/28123475 http://dx.doi.org/10.3892/etm.2016.3910

Ejemplares similares

Study on Correlation between Type 2 Diabetes and No-Reflow after PCI
por: Zhao, Su-Rui, et al.
Publicado: (2022)

The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI
por: Xiang, Yi, et al.
Publicado: (2019)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD
por: Hosoda, Hayato, et al.
Publicado: (2023)

Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients
por: Li, Jing Wei, et al.
Publicado: (2016)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
por: Golshani, Samad, et al.
Publicado: (2022)

The predictive value of eosinophil levels on no-reflow in patients with STEMI following PCI: a retrospective cohort study
por: Mo, De-Gang, et al.
Publicado: (2022)

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion
por: Zhao, X.J., et al.
Publicado: (2014)

Autologous blood injection intracoronary artery for treating slow‐flow and no‐reflow in acute coronary syndrome related to primary pci
por: Truong Hoai, Lam, et al.
Publicado: (2022)

Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI
por: Li, Hui, et al.
Publicado: (2018)

Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial
por: An, Su, et al.
Publicado: (2021)

The combination assessment of lipid pool and thrombus by optical coherence tomography can predict the filter no-reflow in primary PCI for ST elevated myocardial infarction
por: Negishi, Yosuke, et al.
Publicado: (2017)

Lipidomic Predictors of Coronary No-Reflow
por: Surendran, Arun, et al.
Publicado: (2023)

Capillary pericytes mediate coronary no-reflow after myocardial ischaemia
por: O'Farrell, Fergus M, et al.
Publicado: (2017)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

A Practical Method for No-Reflow Treatment
por: Cetin, Mustafa, et al.
Publicado: (2016)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis
por: Dai, Weiran, et al.
Publicado: (2018)

Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory
por: Berg, Ryan, et al.
Publicado: (2012)

Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015)

No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2020)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Delayed Treatment With Hypothermia Protects Against the No‐Reflow Phenomenon Despite Failure to Reduce Infarct Size
por: Hale, Sharon L., et al.
Publicado: (2013)

Suppression of NF-κB Reduces Myocardial No-Reflow
por: Zeng, Min, et al.
Publicado: (2012)

Effects of streptokinase on reflow in rescue percutaneous coronary intervention
por: Sanatkar, Masoud, et al.
Publicado: (2013)

No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
por: Lim, Sang Yup
Publicado: (2016)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

Efficacy of alternate-day versus everyday dosing of atorvastatin
por: Pramanik, Sushobhan, et al.
Publicado: (2012)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Role of no reflow and microvascular obstruction in the prognostic stratification of STEMI patients
por: Durante, Alessandro
Publicado: (2018)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data?
por: Namazi, Mohammadhasan, et al.
Publicado: (2021)

Laser-induced selective wax reflow for paper-based microfluidics
por: Zhang, Yajun, et al.
Publicado: (2019)

Thermal Reflow Simulation for PMMA Structures with Nonuniform Viscosity Profile
por: Sidorov, Fedor, et al.
Publicado: (2023)

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction
por: Gavazzoni, Mara, et al.
Publicado: (2017)

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

MRI evaluation of the role of No-Reflow in left ventricular remodeling after Acute Myocardial Infarction (AMI)
por: Liguori, Carlo, et al.
Publicado: (2009)

PCI-to-PCI bridge architecture specification: Revision 1.1
por: PCI Special Interest Group. Portland, OR, USA
Publicado: (1998)

Severe Liver Injury Associated With High-Dose Atorvastatin Therapy
por: Saha, Amit, et al.
Publicado: (2021)

The role of LR-TIMAP/PP1c complex in the occurrence and development of no-reflow
por: Quan, Xiaoyu, et al.
Publicado: (2021)

Effects of High Dose of Atorvastatin for Preventing Periprocedural Ischemic Brain Damage in Patients Undergoing Carotid Artery Stenting (PICAS) in China: A Randomized Controlled Clinical Trial
por: Wang, Haipeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1acbdq32n784r29b6bt0jeaqd7